Collagen Tripeptide F (CTP-F)
Overview
Collagen Tripeptide F is a synthetic tripeptide designed to mimic fragments of native collagen that appear during tissue remodeling. It is hypothesized to bind to fibroblast surface receptors and promote extracellular matrix deposition, thereby accelerating wound healing and connective tissue repair. The tripeptide structure is intended to enhance bioavailability compared to larger collagen molecules.
Key Research Findings
Preclinical studies in cell culture and animal wound models have suggested enhanced collagen synthesis and fibroblast proliferation. Clinical trial data in humans remain limited, and peer-reviewed publications documenting efficacy in controlled settings are sparse.
Topical, Subcutaneous injection
Research Phase
Interested in Collagen Tripeptide F (CTP-F)?
Find a verified provider experienced with Collagen Tripeptide F (CTP-F) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Collagen Tripeptide F (CTP-F) ProviderRelated Peptides
BPC-157
Research PhaseA synthetic gastric pentadecapeptide derived from a protein found in human gastric juice. BPC-157 promotes angiogenesis and the expression of growth factors including VEGF, EGF, and NO-mediated pathways. It has demonstrated cytoprotective and wound-healing properties across multiple tissue types in preclinical models, including tendon, muscle, ligament, and gastrointestinal mucosa.
TB-500 (Thymosin Beta-4)
In Clinical TrialsThymosin Beta-4 is a 43-amino acid actin-sequestering protein involved in cell migration, differentiation, and tissue repair. It promotes wound healing by upregulating cell-building proteins such as actin and laminin, facilitating cell migration to sites of injury. TB-500 also has anti-inflammatory properties mediated through NF-kB pathway modulation.
GHK-Cu
Research PhaseA naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva, and urine. GHK-Cu activates tissue remodeling by stimulating collagen synthesis, glycosaminoglycan production, and angiogenesis while suppressing fibrinogen synthesis. It modulates the activity of matrix metalloproteinases and influences over 4,000 genes related to tissue repair.
DSIP (Delta Sleep-Inducing Peptide)
Research PhaseA naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) originally isolated from cerebral venous blood of rabbits during induced sleep. DSIP modulates sleep architecture by promoting delta wave (slow-wave) sleep through interactions with the GABAergic system and hypothalamic sleep centers. It also exhibits stress-protective, analgesic, and neuromodulatory properties.